In this video Prof John McMurray (Glasgow University Hospital, Glasgow,UK) and Prof Mikhail Kosiborod (Saint Luke's Mid America Heart Institute, Kansas City, US) discuss the DAPA-HF trial.
Filmed by Radcliffe Cardiology.
This interview is a component of a wider Radcliffe Education programme entitled,'Current and emerging data on SGLT2 inhibitors in heart failure'. Certified accreditation of the full programme is pending following application to the European Board for Accreditation in Cardiology (EBAC). Once accredited the programme will be available on www.radcliffeeducation.com.
Interviewer: Rob Barclay
Videographer: Tom Green
This video was partially funded by an unrestricted educational grant from AstraZeneca.